AAREY DRUGS & PHARMACEUTICALS LTD.
BSE: 524412
values in crores
Revenue & Profit Trend
in croresRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q3 FY2026 | Q2 FY2026 | Q1 FY2026 | Q4 FY2025 | Q3 FY2025 | Q2 FY2025 |
|---|---|---|---|---|---|---|
| INCOME | ||||||
| Revenue | 96.43+14.6% | 84.16-17.7% | 102.21-5.4% | 108.10-19.2% | 133.79+27.2% | 105.14 |
| Other Income | 4.18+427.6% | 0.79-48.9% | 1.55-79.4% | 7.54+1008.5% | 0.68+3300.0% | 0.02 |
| Total Income | 100.61+18.4% | 84.95-18.1% | 103.76-10.3% | 115.64-14.0% | 134.47+27.9% | 105.16 |
| EXPENSES | ||||||
| Expenditure | 99.68+19.4% | 83.47-18.2% | 102.03-10.5% | 114.01-14.3% | 133.07+28.7% | 103.42 |
| Tax | -0.35-177.3% | 0.46+28.4% | 0.36-69.1% | 1.15+69.3% | 0.68+354.7% | 0.15 |
| PROFIT | ||||||
| PBT | 0.92-37.7% | 1.48-14.3% | 1.73+6.4% | 1.63+16.1% | 1.40-19.8% | 1.75 |
| Net Profit | 1.28+24.9% | 1.02-25.4% | 1.37+191.7% | 0.47-34.5% | 0.72-55.0% | 1.60 |
| KEY METRICS | ||||||
| OPM % | -1.57%-4.71pp | 3.14%+1.47pp | 1.67%+6.16pp | -4.49%-3.92pp | -0.57%-0.31pp | -0.26% |
| NPM % | 1.27%+0.07pp | 1.20%-0.12pp | 1.32%+0.91pp | 0.41%-0.12pp | 0.53%-0.99pp | 1.52% |
| EPS | 0.20-44.4% | 0.36-25.0% | 0.48+2300.0% | 0.02-92.3% | 0.26-54.4% | 0.57 |
Corporate Events
Board MeetingAREYDRG
202629May
Board Meeting
To consider and approve the Audited Financial Results for th…
BSE Filing ↗ Board MeetingAREYDRG
202530May
Board Meeting
Consider and approve the Audited Financial statement for the…
BSE Filing ↗ Board MeetingAREYDRG
202514Feb
Board Meeting
consider and approve Unaudited Financial statement for the q…
BSE Filing ↗ Board MeetingAREYDRG
202414Nov
Board Meeting
Consider and approve the Unaudited Financial statement for t…
BSE Filing ↗ Board MeetingAREYDRG
202414Aug
Board Meeting
Consider and approve the Unaudited Financial statement for t…
BSE Filing ↗ Board MeetingAREYDRG
202430May
Board Meeting
consider and approve the Audited Financial statement for the…
BSE Filing ↗